Reuters – A U.S. Food and Drug Administration review found the risk of a serious skin disorder is greater with MRI imaging contrast agents made by GE Healthcare, Bayer AG’s and Covidien, according to an agency memo released on Wednesday.
Reuters – Rituxan, a drug used to treat cancer and rheumatoid arthritis, may help slow the development of newly discovered type 1 or juvenile diabetes, researchers reported on Wednesday.
Reuters – Researchers in Italy said on Wednesday they have developed a test that identifies most people with autoimmune pancreatitis, which could make it easier for doctors to distinguish it from pancreatic cancer, one of the deadliest types of cancer.
HealthDay – (HealthDay News) — Eating is no fun if it hurts to swallow.
Uncomfortable squeezing or burning could be felt anywhere from the upper
neck to behind the breastbone.
HealthDay – (HealthDay News) — Insomnia is a broad term that may include
difficulty sleeping through the night, or problems falling asleep in the
first place.
HealthDay – WEDNESDAY, Nov. 25 (HealthDay News) — An herb called Brazilian mint
treats pain as effectively as some synthetic drugs, English researchers
report.
HealthDay – WEDNESDAY, Nov. 25 (HealthDay News) — Thanksgiving is a time of eating
turkey, gathering with family — and sometimes taking your elderly loved
one to the emergency room.
HealthDay – WEDNESDAY, Nov. 25 (HealthDay News) — It’s known that eating a lot of
salt puts people at greater risk of high blood pressure. Now there’s
confirmation of a corollary: High salt intake also translates to
significantly greater risk of cardiovascular disease and stroke.
HealthDay – Here are some of the latest health and medical news developments,
compiled by editors of HealthDay:
HealthDay – WEDNESDAY, Nov. 25 (HealthDay News) — Mitochondrial damage
causes people with type 2 diabetes to lose insulin-producing cells, a
finding that could lead to new treatments, U.S. researchers say.